title: Histamine H₃ receptors, the complex interaction with dopamine and its implications for addiction.
abstract: Histamine H₃ receptors are best known as presynaptic receptors inhibiting the release of histamine, as well as other neurotransmitters including acetylcholine and dopamine. However, in the dorsal and ventral striatum, the vast majority of H₃ receptors are actually located postsynaptically on medium sized spiny output neurons. These cells also contain large numbers of dopamine (D₁ and D₂) receptors and it has been shown that H₃ receptors form heterodimers with both D₁ and D₂ receptors. Thus, the anatomical localization of H₃ receptors suggests a complex interaction that could both enhance and inhibit dopaminergic neurotransmission. Dopamine, especially within the striatal complex, plays a crucial role in the development of addiction, both in the initial reinforcing effects of drugs of abuse, as well as in maintenance, relapse and reinstatement of drug taking behaviour. It is, therefore, conceivable that H₃ receptors can moderate the development and maintenance of drug addiction. In the present review, we appraise the current literature on the involvement of H₃ receptors in drug addiction and try to explain these data within a theoretical framework, as well as provide suggestions for further research.
authors: School of Psychology, Victoria University, Wellington, New Zealand. bart.ellenbroek@vuw.ac.nz
authors: B A
authors: BA
authors: Ellenbroek
mesh_terms: D000818:Animals; D016739:Behavior, Addictive / Q000503:physiopathology; D003342:Corpus Striatum / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D006632:Histamine / Q000378:metabolism; D006636:Histamine Release / Q000502:physiology; D006801:Humans; D017447:Receptors, Dopamine D1 / Q000378:metabolism; D017448:Receptors, Dopamine D2 / Q000378:metabolism; D018100:Receptors, Histamine H3 / Q000378:metabolism*; D019966:Substance-Related Disorders / Q000503:physiopathology*; D009435:Synaptic Transmission / Q000502:physiology
chemical_list: D017447:Receptors, Dopamine D1; D017448:Receptors, Dopamine D2; D018100:Receptors, Histamine H3; D006632:Histamine; D004298:Dopamine
keywords: D1 receptors; D2 receptors; H3 receptors; cocaine; direct pathway; dorsal striatum; drugs of abuse; histamine; indirect pathway; psychostimulants; ventral striatum
references: Proc Natl Acad Sci U S A. 1984 Apr;81(8):2572-6
references: 6371818
references: Nat Neurosci. 2005 Nov;8(11):1481-9
references: 16251991
references: Pharmacol Biochem Behav. 1991 Oct;40(2):221-8
references: 1839566
references: Physiol Rev. 2008 Jul;88(3):1183-241
references: 18626069
references: J Immunol. 2007 Jun 15;178(12):8081-9
references: 17548646
references: Prog Neurobiol. 1998 Dec;56(6):613-72
references: 9871940
references: Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2938-42
references: 16477003
references: J Neurochem. 1980 Jan;34(1):91-9
references: 6161214
references: Br J Pharmacol. 1996 Dec;119(8):1656-64
references: 8982515
references: Nature. 2000 Nov 9;408(6809):199-203
references: 11089973
references: Brain Res. 1996 Mar 25;713(1-2):114-24
references: 8724982
references: Cereb Cortex. 2005 Mar;15(3):341-8
references: 15269111
references: J Pharmacol Sci. 2009 Oct;111(2):167-74
references: 19783867
references: J Neurochem. 2007 Oct;103(1):248-58
references: 17623045
references: Eur J Neurosci. 2009 Jun;29(12):2363-74
references: 19490084
references: Neuroreport. 1994 Jan 31;5(5):621-4
references: 8025257
references: Pharmacol Biochem Behav. 2001 Apr;68(4):701-8
references: 11526967
references: Harv Rev Psychiatry. 2004 Nov-Dec;12(6):305-20
references: 15764467
references: Mol Pharmacol. 2005 Jan;67(1):195-203
references: 15465923
references: Biochem Pharmacol. 2007 Apr 15;73(8):1215-24
references: 17343831
references: Neuroscience. 2007 Jun 8;146(4):1536-45
references: 17467187
references: FASEB J. 2001 Apr;15(6):1074-6
references: 11292672
references: J Comp Neurol. 1987 Sep 1;263(1):1-24
references: 2822770
references: Pharmacol Biochem Behav. 2011 May;98(3):449-54
references: 21334368
references: Nat Neurosci. 2010 Sep;13(9):1039-41
references: 20740030
references: Psychopharmacology (Berl). 2009 Mar;202(4):673-87
references: 18843481
references: Trends Neurosci. 2012 Jul;35(7):422-30
references: 22459161
references: Psychopharmacology (Berl). 2003 Jul;168(1-2):3-20
references: 12402102
references: Psychopharmacology (Berl). 1984;84(2):167-73
references: 6438676
references: J Physiol. 1910 Dec 31;41(5):318-44
references: 16993030
references: Neuron. 2011 Jun 9;70(5):855-62
references: 21658580
references: J Physiol. 1959 Dec;149:34-42
references: 13844399
references: Br J Pharmacol. 2011 Nov;164 Suppl 1:S1-324
references: 22040146
references: J Neurosci. 2010 Dec 8;30(49):16567-72
references: 21147996
references: Eur J Neurosci. 2011 Apr;33(7):1197-204
references: 21366724
references: Neuropsychopharmacology. 1996 Jun;14(6):375-424
references: 8726752
references: Annu Rev Psychol. 1989;40:191-225
references: 2648975
references: Br J Pharmacol. 2008 May;154(2):261-74
references: 18311189
references: J Pharmacol Exp Ther. 2011 Jan;336(1):9-16
references: 20864504
references: J Pharmacol Exp Ther. 2012 Dec;343(3):568-77
references: 22923736
references: Fundam Clin Pharmacol. 1999;13(1):120-2
references: 10027098
references: Annu Rev Neurosci. 2006;29:565-98
references: 16776597
references: J Pharmacol Exp Ther. 2005 Apr;313(1):176-90
references: 15608077
references: Pharmacol Rep. 2012;64(1):191-204
references: 22580536
references: Behav Pharmacol. 1990;1(4):355-363
references: 11175420
references: Proc Natl Acad Sci U S A. 1988 Jul;85(14):5274-8
references: 2899326
references: Behav Pharmacol. 2009 Dec;20(8):688-94
references: 19881334
references: Br J Pharmacol. 2001 May;133(1):165-71
references: 11325806
references: Mol Pharmacol. 1999 Jun;55(6):1101-7
references: 10347254
references: Neuron. 2011 Feb 24;69(4):680-94
references: 21338879
references: Neuropsychopharmacology. 2010 Jan;35(1):217-38
references: 19710631
references: Br J Pharmacol. 2011 Apr;162(8):1770-80
references: 21198550
references: Synapse. 2001 Mar 1;39(3):257-66
references: 11169774
references: J Neurosci. 2007 Nov 28;27(48):13140-50
references: 18045908
references: Neuroscience. 1984 May;12(1):1-16
references: 6462443
references: Trends Neurosci. 2010 Jun;33(6):267-76
references: 20207024
references: Psychopharmacology (Berl). 1976 Aug 17;48(3):311-8
references: 823588
references: J Physiol. 1996 Oct 1;496 ( Pt 1):175-84
references: 8910206
references: J Neurosci. 2003 Oct 8;23(27):9016-23
references: 14534235
references: Br J Pharmacol. 2009 May;157(1):64-75
references: 19413572
references: J Physiol. 2007 Sep 1;583(Pt 2):731-42
references: 17627982
references: Nat Neurosci. 2006 Aug;9(8):1050-6
references: 16829955
references: Neuropsychopharmacology. 2004 Apr;29(4):705-17
references: 14735131
references: J Biol Chem. 2011 Feb 18;286(7):5846-54
references: 21173143
references: Pharmacol Biochem Behav. 2006 Apr;83(4):561-9
references: 16678245
references: Neuron. 2010 Jun 24;66(6):896-907
references: 20620875
references: Experientia. 1967 Jan 15;23(1):21-2
references: 6031554
references: J Pharmacol Exp Ther. 2005 Feb;312(2):733-41
references: 15494551
references: Neurobiol Dis. 2001 Aug;8(4):707-16
references: 11493035
references: Pharmacol Biochem Behav. 1988 Aug;30(4):1051-7
references: 3147458
references: Behav Brain Res. 2005 May 7;160(1):161-8
references: 15836911
references: Trends Neurosci. 2007 May;30(5):220-7
references: 17400299
references: Br J Pharmacol. 2009 May;157(1):55-63
references: 19413571
references: Fundam Clin Pharmacol. 2006 Aug;20(4):373-8
references: 16867021
references: J Neurosci. 2002 Nov 1;22(21):9604-11
references: 12417685
references: J Physiol. 1941 Sep 8;100(2):147-58
references: 16991515
references: Depress Anxiety. 2012 Apr;29(4):295-306
references: 22147558
references: J Neurochem. 2012 Jan;120(2):202-9
references: 22043863
references: Psychopharmacology (Berl). 1991;105(2):151-6
references: 1839063
references: Neurosci Biobehav Rev. 1998 Mar;22(2):335-45
references: 9579323
references: Neuropsychopharmacology. 2011 Sep;36(10):2030-40
references: 21654737
references: Nat Neurosci. 2010 Sep;13(9):1120-7
references: 20711185
references: J Pharmacol Exp Ther. 2010 Jan;332(1):164-72
references: 19815811
references: Psychopharmacology (Berl). 2003 Jul;168(1-2):109-117
references: 12520312
references: Nat Rev Neurosci. 2011 Oct 12;12(11):623-37
references: 21989194
references: J Pharmacol Exp Ther. 2007 Jun;321(3):1032-45
references: 17327487
references: Behav Pharmacol. 2010 Mar;21(2):153-60
references: 20168211
references: Science. 2007 Mar 2;315(5816):1267-70
references: 17332411
references: Psychopharmacology (Berl). 1995 Jul;120(1):10-20
references: 7480530
references: Psychopharmacology (Berl). 2011 Apr;214(4):829-41
references: 21086115
references: J Neurosci. 2007 Nov 14;27(46):12655-63
references: 18003845
references: Neuropharmacology. 2008 Aug;55(2):190-7
references: 18547596
references: Psychopharmacology (Berl). 2009 Jan;201(4):483-94
references: 18762914
references: Curr Drug Abuse Rev. 2012 Mar;5(1):3-31
references: 22126708
references: Nature. 1983 Apr 28;302(5911):832-7
references: 6188956
references: Neuropsychopharmacology. 2008 Jul;33(8):1807-17
references: 17851536
references: Neuropharmacology. 2011 Jun;60(7-8):1193-9
references: 21044640
references: Neuroscience. 2002;114(1):173-93
references: 12207964
references: Neuropsychopharmacology. 2009 Jun;34(7):1774-82
references: 19177067
references: Brain Res Brain Res Rev. 1993 Sep-Dec;18(3):247-91
references: 8401595
references: Exp Brain Res. 1990;80(2):374-80
references: 2358050
references: Pharmacol Biochem Behav. 1998 May;60(1):55-60
references: 9610924
references: Addict Biol. 2007 Sep;12(3-4):227-462
references: 17678505
references: Neuron. 2008 Mar 13;57(5):760-73
references: 18341995
references: J Cereb Blood Flow Metab. 2012 Jul;32(7):1248-58
references: 22234338
references: Mol Pharmacol. 2001 Jan;59(1):1-8
references: 11125017
references: Psychol Rev. 1987 Oct;94(4):469-92
references: 3317472
references: J Physiol. 2001 Aug 1;534(Pt 3):791-803
references: 11483709
references: Psychopharmacology (Berl). 2010 Jan;208(1):75-86
references: 19911169
references: Neurosci Biobehav Rev. 2004 Jan;27(8):739-49
references: 15019424